Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

1d-1-O-tert-Butyl-diphenyl-silyl-2,3,6-O-tris-(meth-oxy-methyl-ene)-myo-inositol 4,5-bis-(dibenzyl-phosphate).

ABSTRACT: THE TITLE COMPOUND [SYSTEMATIC NAME: tetra-benzyl (1R,2R,3S,4R,5R,6S)-4-(tert-butyl-diphenyl-sil-yloxy)-3,5,6-tris-(meth-oxy-meth-oxy)cyclo-hexane-1,2-diyl bis-phosphate], C(56)H(68)O(15)P(2)Si, was isolated as an inter-mediate in the preparation of a phosphatidylinositol phosphate for biological studies. In the crystal, the mol-ecules are connected via one methyl-ene C-H⋯π and two weak phen-yl-ether C-H⋯O inter-actions. One benz-yloxy group is disordered over two overlapping positions with an occupancy ratio of 0.649 (7):0.351 (7).

SUBMITTER: Anderson RJ

PROVIDER: S-EPMC3297945 | biostudies-literature | 2012 Mar

REPOSITORIES: biostudies-literature

ACCESS DATA

Json Xml

Publications

1d-1-O-tert-Butyl-diphenyl-silyl-2,3,6-O-tris-(meth-oxy-methyl-ene)-myo-inositol 4,5-bis-(dibenzyl-phosphate).

Anderson Regan J RJ Gainsford Graeme J GJ

Acta crystallographica. Section E, Structure reports online 20120229 Pt 3

THE TITLE COMPOUND [SYSTEMATIC NAME: tetra-benzyl (1R,2R,3S,4R,5R,6S)-4-(tert-butyl-diphenyl-sil-yloxy)-3,5,6-tris-(meth-oxy-meth-oxy)cyclo-hexane-1,2-diyl bis-phosphate], C(56)H(68)O(15)P(2)Si, was isolated as an inter-mediate in the preparation of a phosphatidylinositol phosphate for biological studies. In the crystal, the mol-ecules are connected via one methyl-ene C-H⋯π and two weak phen-yl-ether C-H⋯O inter-actions. One benz-yloxy group is disordered over two overlapping positions with an o ...[more]

PMID: 22412748

Similar Datasets

1,4-Bis[4-(tert-butyl-diphenyl-silyl)buta-1,3-diyn-yl]benzene.

Project description:The title centrosymmetric mol-ecule, C(46)H(42)Si(2), is composed of a central benzene ring with buta-1,3-diynyl chains at positions 1 and 4. These chains are terminated by tert-butyl-diphenyl-silyl groups, hence the molecule is dumbbell in shape. The mol-ecules are connected via C-H⋯π inter-actions in the structure, so forming an undulating two-dimensional network in the bc plane. There is also a weak π-π inter-action involving centrosymmetrically related phenyl rings with a centroid-centroid distance of 3.8359 (11) Å.

| S-EPMC2983810 | biostudies-literature

2-O-tert-Butyl-dimethyl-silyl-4,6-O-ethyl-idene-myo-insitol 1,3,5-orthoformate.

Project description:In the title compound, C(15)H(26)O(6)Si, the dioxa six-membered ring bonded to the myo-inositol skeleton is in a boat conformation while the rest of the six-membered rings adopt chair conformations.

| S-EPMC3006906 | biostudies-literature

O-(tert-Butyl-dimethyl-silyl)tris-(O-4-methyl-phenyl-sulfon-yl)penta-erythritol.

Project description:IN THE TITLE COMPOUND [SYSTEMATIC NAME: (tert-butyl-dimethyl-silyl)methane-triyl tris-(4-methyl-benzene-sulfonate)], C(32)H(44)O(10)S(3)Si, the central C atom and the Si(IV) center are in a tetra-hedral configuration. The inter-planar angles between pairs of the three benzene rings of the 4-methyl-phenyl-sulfonyl units are 41.15?(10), 18.11?(10) and 44.09?(10)°. C-H?? inter-actions are observed in the crystal structure. Mol-ecules are linked into screw chains along the b axis by weak C-H?O inter-actions. Weak intramolecular C-H?O hydrogen bonds are also present.

| S-EPMC2962104 | biostudies-literature

Effects of myo-inositol plus alpha-lactalbumin in myo-inositol-resistant PCOS women.

Project description:BackgroundMyo-inositol (MI), successfully used in polycystic ovary syndrome (PCOS), was administered with α-LA to exploit its action of favouring the passage of other molecules through biological barriers, and also considering its anti-inflammatory effect.MethodsPCOS patients, according to the Rotterdam ESHRE-ASRM criteria, with anovulation and infertility > 1 year, were included in this open and prospective study. The preliminary phase was aimed at determining a set of MI-resistant PCOS patients. This treatment involved 2 g MI, taken twice per day by oral route, for three months. The Homeostasis Model Assessment (HOMA) index and MI plasma levels were measured. In the main phase, previously selected MI-resistant patients received the same daily amount of MI plus 50 mg α-LA twice a day, for a further three months. Ovulation was assessed using ultrasound examination on days 12, 14 and 20 of the cycle. The HOMA index, lipid, hormone and MI plasma levels were detected at baseline and at the end of this phase.ResultsThirty-seven anovulatory PCOS subjects were included in the study. Following MI treatment, 23 of the 37 women (62%) ovulated, while 14 (38%) were resistant and did not ovulate. In the latter group, MI plasma levels did not increase. These MI-resistant patients underwent treatment in the main phase of the study, receiving MI and α-LA. After this combined treatment, 12 (86%) of them ovulated. Their MI plasma levels were found to be significantly higher than at baseline; also, a hormone and lipid profile improvement was recorded.ConclusionThe combination of MI with α-LA allowed us to obtain significant progress in the treatment of PCOS MI-resistant patients. Therefore, this new formulation was able to re-establish ovulation, greatly increasing the chances of desired pregnancy.Trial registrationClinical trial registration number: NCT03422289 ( ClinicalTrials.gov registry).

| S-EPMC5944130 | biostudies-literature

Dephosphorylation of 1D-myo-inositol 1,4-bisphosphate in rat liver.

Project description:Dephosphorylation of 1D-myo-inositol 1,4-bisphosphate [Ins(1,4)P2] in rat liver is catalysed by a cytosolic phosphatase that removes the 1-phosphate group. The Km for Ins(1,4)P2 is approx. 17 microM. Li+ (100 mM) causes 50% inhibition of Ins(1,4)P2 phosphatase activity when activity is measured at the very low substrate concentration of 10 nM, but on raising the substrate concentration to 100 microM there is a greater than 10-fold increase in sensitivity to Li+, suggesting that Li+ acts mainly, but not entirely, as an uncompetitive inhibitor of Ins(1,4)P2 phosphatase. In addition, rat liver cytosol shows Li+-sensitive phosphatase activity against 1D-myo-inositol 1-,3- and 4-monophosphates. The Ins(1,4)P2 1-phosphatase and inositol monophosphatase activities all share an apparent Mr of 47 x 10(3), as determined by gel-filtration chromatography. However, the Ins(1,4)P2 1-phosphatase is more sensitive to inactivation by heat, and can be separated from inositol monophosphatase activity by anion-exchange chromatography. We conclude that rat liver cytosol contains an Ins(1,4)P2 1-phosphatase that is distinct from, but in many ways similar to, inositol monophosphatase.

| S-EPMC1135135 | biostudies-other

2-Benzyl-myo-inositol monohydrate.

Project description:The title structure, C(13)H(18)O(6)·H(2)O, contains two independent 2-benzyl-myo-inositol and water mol-ecules. In the crystal, the mol-ecules are strongly hydrogen bonded into an infinite two dimensional network utilizing all OH protons.

| S-EPMC2971447 | biostudies-literature

Stereoselective Voltammetric Biosensor for Myo-Inositol and D-Chiro-Inositol Recognition

Project description: Not available

| S-EPMC10674735 | biostudies-literature

1,4-Bis(dimethyl-silyl)-2,5-diphenyl-benzene.

Project description:The mol-ecule of the title compound, C(22)H(26)Si(2), is centrosymmetric. The dihedral angle between the central benzene ring and its phenyl substituents is 67.7?(2)°. The crystal packing is stabilized by van der Waals forces.

| S-EPMC2983822 | biostudies-literature

Myo-inositol oxygenase is important for the removal of excess myo-inositol from syncytia induced by Heterodera schachtii in Arabidopsis roots.

Project description:The enzyme myo-inositol oxygenase is the key enzyme of a pathway leading from myo-inositol to UDP-glucuronic acid. In Arabidopsis, myo-inositol oxygenase is encoded by four genes. All genes are strongly expressed in syncytia induced by the beet cyst nematode Heterodera schachtii in Arabidopsis roots. Here, we studied the effect of a quadruple myo-inositol oxygenase mutant on nematode development. We performed metabolite profiling of syncytia induced in roots of the myo-inositol oxygenase quadruple mutant. The role of galactinol in syncytia was studied using Arabidopsis lines with elevated galactinol levels and by supplying galactinol to wild-type seedlings. The quadruple myo-inositol oxygenase mutant showed a significant reduction in susceptibility to H. schachtii, and syncytia had elevated myo-inositol and galactinol levels and an elevated expression level of the antimicrobial thionin gene Thi2.1. This reduction in susceptibility could also be achieved by exogenous application of galactinol to wild-type seedlings. The primary function of myo-inositol oxygenase for syncytium development is probably not the production of UDP-glucuronic acid as a precursor for cell wall polysaccharides, but the reduction of myo-inositol levels and thereby a reduction in the galactinol level to avoid the induction of defence-related genes.

| S-EPMC4285123 | biostudies-literature

Anaerobic peroxisomes in Entamoeba histolytica metabolize myo-inositol

Project description:E. histolytica is believed to be devoid of peroxisomes, like most anaerobic protists. In this work, we provided the first evidence that peroxisomes are present in E. histolytica, although the set of proteins (peroxins) responsible for peroxisome biogenesis was reduced to only seven members (Pex1, Pex6, Pex5, Pex11, Pex14, Pex16, and Pex19). Targeting matrix proteins to peroxisomes is reduced to the PTS1-dependent pathway mediated via the soluble Pex5 receptor, while the PTS2 receptor Pex7 is absent. Immunofluorescence microscopy showed that peroxisomal markers (Pex5, Pex14, Pex16, Pex19) are present in vesicles distinct from mitosomes, the endoplasmic reticulum and the endosome/phagosome system, except Pex11, which has dual localization in peroxisomes and mitosomes. Immunoelectron microscopy revealed that Pex14 localized to vesicles of approximately 90-100 nm in diameter. Proteomic analyses of affinity-purified peroxisomes and in silico PTS1 predictions provided datasets of 655 and 56 peroxisomal candidates, respectively; however, only six proteins were shared by both datasets, including myo-inositol dehydrogenase (myo-IDH). Peroxisomal NAD-dependent myo-IDH appeared to be a dimeric enzyme with high affinity to myo-inositol (Km 0,044 mM) and can utilize also scyllo-inositol, D-glucose and D-xylose as substrates. Phylogenetic analyses revealed that orthologs of myo-IDH with PTS1 are present in E. dispar, E. nutalli and E. moshkovskii but not in E. invadens, and form a monophyletic clade of mostly peroxisomal orthologs with free-living M. balamuthi and P. schiedti. The presence of peroxisomes in E. histolytica and other archamoebae breaks the paradigm of peroxisome absence in anaerobes and provides a new potential target for the development of antiparasitic drugs.

2021-10-29 | PXD026653 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data